Nice, France

Antoine Millet

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antoine Millet: Innovator in Cancer Treatment

Introduction

Antoine Millet is a notable inventor based in Nice, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on creating effective solutions for combating cancer, showcasing his dedication to improving healthcare.

Latest Patents

Antoine Millet holds a patent for "Substituted hydrophobic benzene sulfonamide thiazole compounds for use in treating cancer." This invention relates to a compound of general formula (I) that includes various substituents, which are useful in the treatment of cancers. The compounds are designed to provide therapeutic benefits and are characterized by their complex chemical structures, which include various functional groups and their pharmaceutically acceptable salts and isomers.

Career Highlights

Throughout his career, Antoine Millet has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université Nice Sophia Antipolis. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Antoine Millet has collaborated with notable colleagues, including Stephane Rocchi and Rachid Benhida. These partnerships have enhanced his research efforts and facilitated the development of innovative solutions in cancer treatment.

Conclusion

Antoine Millet's contributions to cancer treatment through his patented inventions and collaborations with esteemed institutions highlight his commitment to advancing medical science. His work continues to inspire future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…